A First for AI and Vaccine
Abigail
A FIRST FOR AI AND FOR THE WORLD – A NEW
VACCINE
As of 5 th June, 2026, researchers at the University of Cambridge and the university
spinout company DIOSynVax (DVX) Ltd. have begun human trials on a revolutionary
piece of medical technology. Artificial intelligence has been used to develop a
"fundamentally new" type of vaccine that could protect against large swathes of
viruses and even prevent pandemics! This vaccine was designed entirely by AI, and
was engineered to work on all coronaviruses which would include all Covid variants
as well.
How does this work? The Cambridge researchers took known genetic codes from a
range of coronaviruses, which were then analysed by AI. It then designed a "super-
antigen" that could train the immune system in such a way it gave protection against
the whole family of viruses – even if they mutated.
Professor Jonathan Heeney, from the Cambridge University said this was the first time
an antigen designed by AI had been trialled in people. Heeney told BBC News: "This
is about making vaccines that protect us, not just from today's viruses, but protect us
from what can cause the next outbreak or disease. This is a fundamental shift in how
we prepare for pandemics."
They are also looking at a vaccine for viral haemorrhagic fevers, which would include
Ebola species. This line of research is wonderful news as we face the looming
possibility of another pandemic caused by the outbreak in the Democratic Republic of
the Congo.
Here’s a fun little word search as we wait for the brilliant scientists of the world to
bring us more uplifting and exciting news: